'No place' for genetic testing to spot young sporting talent or boost performance

November 16, 2015

No child or young athlete should be subjected to genetic testing to spot sporting talent or boost performance, concludes an international panel of experts in a consensus statement published in the British Journal of Sports Medicine.

The scientific evidence on the effectiveness of these commercial tests is simply far too weak to back their use, says the panel of 22 experts in the fields of genomics, exercise, sports performance, disease, injury, and anti-doping.

While the science of genomics has advanced rapidly over the past decade, the ability to interpret the meaning of genetic test results is still at a relatively early stage, says the statement.

But that has not hindered the growth of DIY 'direct to consumer' genetic tests, which claim to be able to talent spot children's athletic prowess or tailor training to maximise performance, it says. Anyone willing to stump up the cost and send a sample of spit or a mouth smear for lab analysis can request one of these tests.

This burgeoning market has prompted fears that the current limited level of knowledge on the genetics of sports performance is being misrepresented for commercial gain, it says.

To inform the consensus statement, the panel looked at the availability of DIY genetic tests. It found 39 companies marketing tests associated with sport or exercise performance or injury--almost twice as many as in 2013, when a similar review found 22.

Since 2013, 14 of the original 22 companies have ceased trading, meaning that 25 companies have entered the market within the past two years.

Claims included: 'Personalise your training based on your sports genetics,' 'Gives parents and coaches early information on their child's genetic predisposition for success in team or individual speed/power or endurance sports,' and 'We use your DNA results to help you lose fat, get lean, build muscle, get fitter.'

For over half (54%) of the 39 companies, it was impossible to find out which gene sequences and variants would be tested, because this information wasn't provided. For the remainder, the average number of variants tested was 6, but ranged from 1 to 27.

But the absence of any good scientific data to guide selection of which variants to test undermines the value of multiple testing, says the statement.

The most popular genetic variants tested were ACTN3 R577X and ACE I/D, both of which have been relatively well studied. While there is some evidence to suggest a link with enhanced physical performance, it is very weak, rendering the predictive value of these tests "virtually zero," says the statement.

Of further concern is that several companies use the results to market additional products, such as training advice and nutritional supplements, for which the evidence is again limited, it says.

The statement emphasises that the speed of change in gene sequencing technology has far outpaced regulation, or universally accepted guidelines. And legislation varies widely among countries--the UK has none, for example.

And it points out the importance of counselling before any genetic test is taken, particularly as this may have implications for health or life insurance--but which is not part of the package offered with these tests.

Furthermore, the sensitive nature of an individual's genetic information should be subject to the highest level of security and confidentiality, says the statement. But it is not at all clear what happens to these data when one of these companies goes under.

"While further evidence will undoubtedly emerge around the genetics of sport performance in the future, the data are currently very limited," says the consensus statement.

"Consequently, in the current state of knowledge, no child or young athlete should be exposed to [direct to consumer] genetic testing to define or alter training or for talent identification aimed at selecting gifted children or adolescents," it concludes.
-end-


BMJ

Related Genetic Testing Articles from Brightsurf:

Genetic testing cost effective for newly diagnosed GIST
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.

Genetic testing could improve screening for osteoporosis
An international team of scientists has developed a novel genetic measure that could dramatically improve how doctors assess the risk of sustaining a fracture due to osteoporosis or fragility

New recommendations on genetic testing for prostate cancer
Genetic testing for prostate cancer is still not common. New guidelines show why it's important, and which genes to test for.

For acute myeloid leukemia, genetic testing is often worth the wait
New tailored therapies offer exciting prospects for treating acute myeloid leukemia (AML), but taking advantage of them may require waiting a week or more for genetic testing before starting treatment, posing a dilemma for doctors and patients facing this deadly and often fast-moving disease.

Genetic testing among individuals with ASD
Professional medical societies recommend certain genetic tests for individuals with autism spectrum disorder (ASD).

Breast cancer patients to be evaluated for genetic testing
The guidance from the ACMG differs from a consensus guideline issued in February by the American Society of Breast Surgeons, which recommended genetic testing for all newly diagnosed patients with breast cancer.

New technique isolates placental cells for non-invasive genetic testing
A new technique for isolating cells carrying the full fetal genome from cervical swabs could enable doctors to diagnose genetic disorders without using needles to harvest cells from the placenta.

BRCA1/2 genetic testing recommendations still leave issues unresolved
The U.S. Preventive Services Task Force offers new guidelines on BRCA1/2 genetic testing.

Does genetic testing pose psychosocial risks?
For the last quarter century, researchers have been asking whether genetic information might have negative psychosocial effects.

Genetic testing has a data problem; New software can help
As at-home genetic testing becomes more popular, companies are grappling with how to store all the accumulating data and how to process results quickly.

Read More: Genetic Testing News and Genetic Testing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.